Stopping Deadly Infections

Nearly 125 years ago, Johnson & Johnson pioneered ready-to-use surgical dressings that helped keep pathogens from infecting wounds. Now, Advanced Sterilization Products (ASP), a division of Ethicon, Inc., is pioneering the reduction of pathogens from health care settings with GLOSAIR™ area disinfection products.

The World Health Organization estimates that in Europe, more than 4 million patients are affected by approximately 4.5 million episodes of health care-associated infections (HAIs) each year, causing 16 million extra days of hospital stay and 37,000 deaths. Another consequence: HAIs place significant cost pressure on hospitals.

GLOSAIR™ helps reduce the risk of HAIs and is on course to become a new standard of care. Studies show that this safe and user-friendly technology—a hydrogen peroxide dry-mist system—is a more effective method of disinfecting health care settings, following cleaning, than sole reliance on manual application of traditional disinfectants.

“These machines have helped us maintain a good standard of cleaning and manage a safe patient environment,” says Paul Andrews, Housekeeping Manager, Dorset County Hospital, England. The local emergency hospital has used GLOSAIR™ 400 Systems to help reduce HAI rates. “We’ve achieved one of the lowest MRSA rates in the National Health System since adding GLOSAIR™ to our infection-prevention practices,” says Andrews.

Since acquiring Gloster Europe in 2009, ASP has leveraged its ability to take GLOSAIR™ to more markets. A global rollout began with launches throughout Europe in 2010; plans are to launch in the U.S. in 2011.

This section contains multiple pages. Click on each page number to advance the page.